Funding for this research was provided by:
National Cancer Institute of the National Institutes of Health (R01CA194178)
Text and Data Mining valid from 2018-11-20
Received: 1 August 2018
Accepted: 6 November 2018
First Online: 20 November 2018
Ethics approval and consent to participate
: The University of Delaware Institutional Review Board approved this research trial (Protocol # 1165185–1) and served as the single IRB of record, consistent with National Institutes of Health NOT-OD-16-094 (ExternalRef removed). Helen F. Graham Cancer Center of Christiana Care Hospital System (Dr. Shannon Virtue, site PI) and Sidney Kimmel Cancer Center of Jefferson University (Dr. Alliric Willis, site PI) served as the primary recruitment sites for this project. The study will be performed in accordance with the Declaration of Helsinki and satisfy the regulatory requirements in the United States of America. Written informed consent will be obtained from all adult participants included in the study. Written informed assent will be obtained from all participants aged 12–17 years with parents also providing written informed consent prior to participation.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.